What did this study find?
This Cochrane review included 13 sham-controlled randomized trials of repetitive TMS for PTSD, with 577 participants. Based on moderate-certainty evidence, the authors concluded that active rTMS probably makes little to no difference to PTSD severity immediately after treatment compared with sham. Study populations and stimulation protocols varied widely.
What are the details of this record?
- Full citation
- Brown R, Cherian K, Jones K, Wickham R, Gomez R, Sahlem G. Repetitive transcranial magnetic stimulation for post-traumatic stress disorder in adults. Cochrane Database Syst Rev. 2024;8(8):CD015040. doi:10.1002/14651858.CD015040.pub2.
- Journal
- Cochrane Database of Systematic Reviews
- Authors
- Brown R, Cherian K, Jones K, Wickham R, Gomez R, Sahlem G
- Study design
- Systematic review and meta-analysis
- Sample size and population
- 13 sham-controlled RCTs, 577 participants
- Evidence grade
- Grade D on the BioReg grading scale
- Reported findings
- Active rTMS probably makes little to no difference to PTSD severity immediately following treatment compared with sham (SMD -0.14, 95% CI -0.54 to 0.27; 3 studies, 99 participants; moderate-certainty evidence). Sensitivity analysis found significant heterogeneity across studies.
- PubMed
- PMID 39092744
- Related categories
- PTSD & Trauma (category grade D to A- (TMS) / B to A- (HRV biofeedback) / F (PEMF))
A positive PEMF study is not evidence for a specific device unless the signal parameters studied, frequency, intensity, waveform, and exposure duration, are reasonably comparable to what that device produces. Where this record does not list those parameters, the source report did not publish them. See the grading methodology. Library last reviewed 2026-08-27.